The current research indicates that E2 upregulates the ERα/SIRT1/PGC-1α signaling pathway and protects mitochondrial function to prevent OVX-induced NAFLD. This evidence concerns the gene ESR1 and metabolic dysfunction-associated steatotic liver disease.